RECORD // Company

Dalrada Technology Group, Inc.

Formerly: DALRADA FINANCIAL CORP; IMAGING TECHNOLOGIES CORP/CA; PERSONAL COMPUTER PRODUCTS INC

Built 2026-11-20T02:09:08Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)

4 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-03-31, filed 2026-05-21 · accession 0001683168-26-004188

Old data: this filer's newest 10-Q or 10-K in SEC company facts is for the period ended 2026-03-31. No later report has XBRL values.

ItemValuePeriodFormFiledAccessionReport
Revenue$2,567,1043 months ended 2026-03-3110-Q2026-05-210001683168-26-0041882026-11-20 02:09 UTCReport an error
Net income (loss)$-4,327,2473 months ended 2026-03-3110-Q2026-05-210001683168-26-0041882026-11-20 02:09 UTCReport an error
Interest expense$-1,041,7673 months ended 2026-03-3110-Q2026-05-210001683168-26-0041882026-11-20 02:09 UTCReport an error
Cash and cash equivalents$82,625at 2026-03-3110-Q2026-05-210001683168-26-0041882026-11-20 02:09 UTCReport an error

Negative as reported in the filing.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0000725394
Ticker
DHTI
EIN
383713274
CUSIP
235990819
Record ID
sx:sec:0000725394

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

19 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-10-07SEC EDGAR company profile2026-11-20 02:09 UTCReport an error
SIC industry7363 Services-Help Supply Services2026-10-07SEC EDGAR company profile2026-11-20 02:09 UTCReport an error
State of incorporationWY2026-10-07SEC EDGAR company profile2026-11-20 02:09 UTCReport an error
Fiscal year end (MMDD)06302026-10-07SEC EDGAR company profile2026-11-20 02:09 UTCReport an error
Business address600 LA TERRAZA BOULEVARD, ESCONDIDO, CA, 920252026-10-07SEC EDGAR company profile2026-11-20 02:09 UTCReport an error
ExchangesOTC2026-10-07SEC EDGAR company profile2026-11-20 02:09 UTCReport an error
Revenue (fiscal year ended 2025-06-30)$20,302,8032025-06-3010-K, XBRL Revenues2026-11-20 02:09 UTCReport an error
Net income (loss) (fiscal year ended 2025-06-30)$-24,646,5812025-06-3010-K, XBRL NetIncomeLoss2026-11-20 02:09 UTCReport an error
Total assets (at 2025-06-30)$18,358,8952025-06-3010-K, XBRL Assets2026-11-20 02:09 UTCReport an error
Stockholders' equity (at 2025-06-30)$-6,753,9092025-06-3010-K, XBRL StockholdersEquity2026-11-20 02:09 UTCReport an error
Cash and cash equivalents (at 2025-06-30)$172,7872025-06-3010-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-20 02:09 UTCReport an error
Operating cash flow (fiscal year ended 2025-06-30)$-17,972,4342025-06-3010-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-20 02:09 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-06-30)$374,4552025-06-3010-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-20 02:09 UTCReport an error
Operating lease liabilities (at 2025-06-30)$3,943,3852025-06-3010-K, XBRL OperatingLeaseLiability2026-11-20 02:09 UTCReport an error
8-K Item 1.02, Termination of a Material Definitive Agreement (filed 2026-10-07)As previously reported in the Current Report on Form 8-K filed by Dalrada Technology Group, Inc. (the “Company”) on September 22, 2026 (the “Prior 8-K”), effective as of December 31, 2025, Genefic, Inc. (“Genefic”), a wholly owned subsidiary of the Company, together with certain of Genefic’s affiliates and subsidiaries, entered into (i) a Master Performance Standby Letter of Credit and Guaranty Agreement (the “MGA”) with IBS Equity Fund III, LLC (“IBS Fund III”) and (ii) a Master Credit, Security, and Account Purchase Agreement (the “MCSPA”) with IBS Private Credit Fund IV, LLC (“IBS Fund IV” and, together with IBS Fund III, “IBS”), together with related guaranties, a stock and unit pledge…2026-10-07SEC EDGAR 8-K 0001683168-26-007677 (text as filed, excerpt)2026-11-20 02:09 UTCReport an error
8-K Item 8.01, Other Events (filed 2026-10-07)The Prior 8-K reported, under Item 2.04, the IBS Notices and IBS’s demand for payment of approximately $1,162,246. As a result of the Settlement Agreement and the Closing described in Item 1.02 of this Current Report, the IBS Notices have been withdrawn, the asserted events of default and acceleration are of no force or effect, and the Company’s and its subsidiaries’ obligations in respect of the amounts demanded have been fully and finally resolved for the $20,000 Settlement Amount. Dalrada and IBS have amicably resolved their commercial differences concerning Project RX and mutually concluded the financing relationship through a settlement providing for mutual releases without an…2026-10-07SEC EDGAR 8-K 0001683168-26-007677 (text as filed, excerpt)2026-11-20 02:09 UTCReport an error
8-K Item 1.02, Termination of a Material Definitive Agreement (filed 2026-09-22)Effective as of December 31, 2025, Genefic, Inc. (“Genefic”), a wholly owned subsidiary of Dalrada Technology Group, Inc. (the “Company”), together with certain of Genefic’s affiliates and subsidiaries, entered into (i) a Master Performance Standby Letter of Credit and Guaranty Agreement (the “MGA”) with IBS Equity Fund III, LLC (“IBS Fund III”), and (ii) a Master Credit, Security, and Account Purchase Agreement (the “MCSPA”) with IBS Private Credit Fund IV, LLC (“IBS Fund IV” and, together with IBS Fund III, “IBS”). In connection with the MGA and the MCSPA, the parties entered into a number of related schedules and ancillary documents, including a Secured Promissory Note issued by Genefic…2026-09-22SEC EDGAR 8-K 0001683168-26-007291 (text as filed, excerpt)2026-11-20 02:09 UTCReport an error
8-K Item 2.04, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement (filed 2026-09-22)On September 16, 2026, the Company and Genefic received a Master Notice of Events of Default, Termination, Acceleration, Payment and Collateral Demands, and Status of Remedies dated September 15, 2026 (the “Master Notice”) from IBS, together with a series of instrument-specific notices of the same date (collectively with the Master Notice, the “Default Notices”), including a notice addressed to the Company in its capacity as corporate guarantor and credit party under the MCSPA and a notice addressed to Mr. Bonar in his capacity as personal guarantor. In the Default Notices, IBS purports to declare that Events of Default have occurred and are continuing under the Financing Agreements. The…2026-09-22SEC EDGAR 8-K 0001683168-26-007291 (text as filed, excerpt)2026-11-20 02:09 UTCReport an error
8-K Item 8.01, Other Events (filed 2026-09-22)Cautionary Note Regarding Forward-Looking Statements. This Current Report on Form 8-K contains forward-looking statements, including statements regarding the Company’s belief that it has meritorious defenses, its intention to defend against claims by IBS, and the potential effects of any exercise of remedies by IBS. Words such as “believes,” “intends,” “may,” “could,” “expects” and similar expressions are intended to identify forward-looking statements. These statements are based on management’s current beliefs and expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including the outcome of any dispute or litigation with IBS, the…2026-09-22SEC EDGAR 8-K 0001683168-26-007291 (text as filed, excerpt)2026-11-20 02:09 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.